Results 111 to 120 of about 1,936 (153)

Ceftolozane–tazobactam: A new-generation cephalosporin

open access: yesAmerican Journal of Health-System Pharmacy, 2015
The chemistry, pharmacokinetic and pharmacodynamic properties, efficacy, and safety of the recently introduced combination antimicrobial agent ceftolozane-tazobactam are reviewed.Ceftolozane-tazobactam (Zerbaxa, Cubist Pharmaceuticals) is a cephalosporin β-lactam and β-lactamase inhibitor marketed as a fixed-dose combination agent for the treatment of ...
Cluck, David   +4 more
openaire   +4 more sources

Ceftolozane-Tazobactam Activity Against Pseudomonas aeruginosa Clinical Isolates From U.S. Hospitals: Report From the PACTS Antimicrobial Surveillance Program, 2012 to 2015.

open access: yesAntimicrobial Agents and Chemotherapy, 2017
The activity of ceftolozane-tazobactam was compared to the activities of 7 antimicrobials against 3,851 Pseudomonas aeruginosa isolates collected from 32 U.S.
Dee Shortridge   +2 more
exaly   +2 more sources

Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa During Treatment Is Mediated by a Single AmpC Structural Mutation.

open access: yesAntimicrobial Agents and Chemotherapy, 2017
Ceftolozane-tazobactam is a cephalosporin-β-lactamase inhibitor combination that exhibits potent in vitro activity against Pseudomonas aeruginosa , including strains that are resistant to other β-lactams ...
Liang Chen   +2 more
exaly   +2 more sources

Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients With an Indwelling External Ventricular Drain.

open access: yesAntimicrobial Agents and Chemotherapy, 2020
The aim of this study was to describe the pharmacokinetics of ceftolozane/tazobactam in plasma and cerebrospinal fluid (CSF) of infected critically ill patients.
Jason Roberts   +2 more
exaly   +2 more sources

Ceftolozane – Tazobactam

Reactions Weekly, 2022
Michelle C. Simpson, Eric G. Schaefer
  +4 more sources

ESBLs and Resistance to Ceftazidime/Avibactam and Ceftolozane/Tazobactam Combinations in Escherichia coli and Pseudomonas aeruginosa. [PDF]

open access: yesJournal of Antimicrobial Chemotherapy, 2019
To evaluate the efficacy of the recently launched β-lactam/β-lactamase inhibitor combinations ceftazidime/avibactam and ceftolozane/tazobactam against ESBL- producing Escherichia coli and Pseudomonas aeruginosa strains.Methods: A series of ESBL ...
Laurent Poirel, Patrice Nordmann
exaly   +1 more source

Ceftolozane and ceftolozane-tazobactam

2018
Ceftolozane (also known as CXA101 and FR264205) is an oxyimino-aminothiazolyl cephalosporin with structural similarity to ceftazidime (Toda et al., 2008). The addition of a 3-amino-2-methylpyrazole in the 4-position improved the minimum inhibitory concentrations against class C betalactamase- producing organisms (Toda et al., 2008).
openaire   +1 more source

Home - About - Disclaimer - Privacy